Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development
- PMID: 35314062
- DOI: 10.1016/j.funbio.2022.01.003
Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development
Abstract
Therapeutic use of psilocybin has become a focus of recent international research, with preliminary data showing promise to address a range of treatment-resistant mental health conditions. However, use of psilocybin as a healing entheogen has a long history through traditional consumption of mushrooms from the genus Psilocybe. The forthcoming adoption of new psilocybin-assisted therapeutic practices necessitates identification of preferred sources of psilocybin; consequently, comprehensive understanding of psilocybin-containing fungi is fundamental to consumer safety. Here we examine psilocybin producing fungi, discuss their biology, diversity, and ethnomycological uses. We also review recent work focused on elucidation of psilocybin biosynthetic production pathways, especially those from the genus Psilocybe, and their evolutionary history. Current research on psilocybin therapies is discussed, and recommendations for necessary future mycological research are outlined.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest JCS is a paid scientific advisor to Back of the Yards Algae Sciences and served on the board of the Entheome Foundation. All other authors declare no conflict of interest.
Similar articles
-
DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.Appl Environ Microbiol. 2022 Dec 20;88(24):e0149822. doi: 10.1128/aem.01498-22. Epub 2022 Nov 29. Appl Environ Microbiol. 2022. PMID: 36445079 Free PMC article.
-
A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Biotechnol Adv. 2023 Dec;69:108247. doi: 10.1016/j.biotechadv.2023.108247. Epub 2023 Sep 1. Biotechnol Adv. 2023. PMID: 37659744 Review.
-
Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster.Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2311245121. doi: 10.1073/pnas.2311245121. Epub 2024 Jan 9. Proc Natl Acad Sci U S A. 2024. PMID: 38194448 Free PMC article.
-
[Levels of psilocybin and psilocin in various types of mushrooms].Soud Lek. 2003 Jul;48(3):45-9. Soud Lek. 2003. PMID: 14631713 Czech.
-
[Hallucinogenic mushrooms].Medicina (Kaunas). 2005;41(12):1067-70. Medicina (Kaunas). 2005. PMID: 16401965 Review. Lithuanian.
Cited by
-
Assessing global fungal threats to humans.mLife. 2022 Sep 22;1(3):223-240. doi: 10.1002/mlf2.12036. eCollection 2022 Sep. mLife. 2022. PMID: 38818220 Free PMC article. Review.
-
In vitro and in vivo metabolism of psilocybin's active metabolite psilocin.Front Pharmacol. 2024 Apr 29;15:1391689. doi: 10.3389/fphar.2024.1391689. eCollection 2024. Front Pharmacol. 2024. PMID: 38741590 Free PMC article.
-
Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon.Cancers (Basel). 2024 Apr 27;16(9):1702. doi: 10.3390/cancers16091702. Cancers (Basel). 2024. PMID: 38730654 Free PMC article. Review.
-
Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.Clin Psychopharmacol Neurosci. 2024 May 31;22(2):222-231. doi: 10.9758/cpn.23.1134. Epub 2023 Nov 30. Clin Psychopharmacol Neurosci. 2024. PMID: 38627070 Free PMC article. Review.
-
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Mol Psychiatry. 2024 Feb 20. doi: 10.1038/s41380-024-02477-w. Online ahead of print. Mol Psychiatry. 2024. PMID: 38378926
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources